These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 6143103)

  • 1. Prophylaxis of systemic yersinosis in thalassaemia major.
    Scharnetzky M; König R; Lakomek M; Tillmann W; Schröter W
    Lancet; 1984 Apr; 1(8380):791. PubMed ID: 6143103
    [No Abstract]   [Full Text] [Related]  

  • 2. Yersinia pseudotuberculosis septicaemia in thalassaemia major.
    Gordts B; Rummens E; deMeirleir L; Butzler JP
    Lancet; 1984 Jan; 1(8367):41-2. PubMed ID: 6140358
    [No Abstract]   [Full Text] [Related]  

  • 3. [Yersinia septicemia in children with thalassaemia major].
    Huang CB; Löhr H
    Changgeng Yi Xue Za Zhi; 1987 Jun; 10(2):185-8. PubMed ID: 3455287
    [No Abstract]   [Full Text] [Related]  

  • 4. Fatal septicemia caused by Yersinia enterocolitica in thalassemia major.
    Pérez Trallero E; Cilla G; López-Lopategui C; Arratibel C
    Pediatr Infect Dis; 1986; 5(4):483-5. PubMed ID: 3725661
    [No Abstract]   [Full Text] [Related]  

  • 5. Yersinia enterocolitis in iron overload.
    Kelly DA; Price E; Jani B; Wright V; Rossiter M; Walker-Smith JA
    J Pediatr Gastroenterol Nutr; 1987; 6(4):643-5. PubMed ID: 3430272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Yersinia infection and hemoglobin disorder. Apropos of 4 cases].
    Pierron H; Gillet R; Perrimond H; Broudeur JC; Soudry G
    Pediatrie; 1990; 45(6):379-82. PubMed ID: 2170907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Yersinia enterocolitica septicaemia.
    Masters AP; Hopkinson RB
    Intensive Care Med; 1988; 14(5):585-7. PubMed ID: 3221013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Yersinia sepsis in patients with iron overload treated with deferoxamine.
    Gallant T; Freedman MH; Vellend H; Francombe WH
    N Engl J Med; 1986 Jun; 314(25):1643. PubMed ID: 3713766
    [No Abstract]   [Full Text] [Related]  

  • 9. [Roles of iron overload and chelating treatment in Yersinia infectious complicated by major thalassemia].
    François P; Bachelot C; Andrini P; Bost M
    Presse Med; 1987 Oct; 16(32):1574-6. PubMed ID: 2958832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Yersinia hepatic abscesses and iron overload.
    Chiesa C; Pacifico L; Renzulli F; Midulla M; Garlaschi L
    JAMA; 1987 Jun; 257(23):3230-1. PubMed ID: 3586244
    [No Abstract]   [Full Text] [Related]  

  • 11. Desferrioxamine and systemic yersiniosis.
    Robins-Browne RM; Prpic JK
    Lancet; 1983 Dec; 2(8363):1372. PubMed ID: 6139711
    [No Abstract]   [Full Text] [Related]  

  • 12. Hearing impairment during deferoxamine therapy for thalassemia major.
    Argiolu F; Diana G; Avignone A; Cao A; Di Ninni S
    J Pediatr; 1991 May; 118(5):826-7. PubMed ID: 2019945
    [No Abstract]   [Full Text] [Related]  

  • 13. Systemic Yersinia enterocolitica infection associated with iron overload and deferoxamine therapy.
    Abcarian PW; Demas BE
    AJR Am J Roentgenol; 1991 Oct; 157(4):773-5. PubMed ID: 1892033
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hepatic abscess due to Yersinia in a child with thalassemia].
    Brunel F; François P; Durand C; Croize J; Jeannoel P
    Pediatrie; 1993; 48(2):159-62. PubMed ID: 8393182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biological and toxic properties of deferoxamine.
    Freedman MH; Bentur Y; Koren G
    Prog Clin Biol Res; 1989; 309():115-24. PubMed ID: 2675081
    [No Abstract]   [Full Text] [Related]  

  • 16. [Yersinia enterocolitica infections and thalassemia major in children].
    Chirio R; Collignon A; Sabbah L; Lestradet H; Torlotin JC
    Ann Pediatr (Paris); 1989 May; 36(5):308; 311-4. PubMed ID: 2662880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Yersinia and iron overload.
    Kelly D; Price E; Wright V; Walker-Smith J; Rossiter M
    Br Med J (Clin Res Ed); 1986 Feb; 292(6517):413. PubMed ID: 3080198
    [No Abstract]   [Full Text] [Related]  

  • 18. Hearing loss attributed to desferrioxamine in patients with beta-thalassaemia major.
    Schindléry C
    Med J Aust; 1988 Jun; 148(12):662-3. PubMed ID: 3380052
    [No Abstract]   [Full Text] [Related]  

  • 19. A prospective randomized controlled trial on the safety and efficacy of alternating deferoxamine and deferiprone in the treatment of iron overload in patients with thalassemia.
    Galanello R; Kattamis A; Piga A; Fischer R; Leoni G; Ladis V; Voi V; Lund U; Tricta F
    Haematologica; 2006 Sep; 91(9):1241-3. PubMed ID: 16956824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Yersinia enterocolitica septicemia in a girl with thalassemia major].
    Fontani C; Valeri M; Pifferi M; Ceccarelli M
    Pediatr Med Chir; 1988; 10(6):657-8. PubMed ID: 3244546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.